Tag Archives: Northwest Biotherapeutics

NWBO stock- Is Northwest Biotherapeutics Inc. a good buy?

NWBO – Northwest Biotherapeutics Inc.

Northwest Biotherapeutics Inc. is a cancer vaccination producing company having its headquarters in Maryland, United States. The company has been working since 1996 and develops the medications for a broader range of solid tumor cancers by leaving the hard side-effects of chemotherapy.  The personalized vaccination of the company is aimed at providing an effective and cost-efficient method for the treatment of cancer.

The company has a 52-week stock range of $0.14-0.40. It basically focuses on the research and development of the most effective medicines for most lethal forms of cancer. DCVax-L is on trial … Read More